Series A (closing imminent)

We are about to close our Series A, led by a large VC firm from the US & Taiwan. Before the closing, we are giving the opportunity to large and small investors to join the round, and contribute with their healthtech expertise.

Our ambitious goal at Xsensio is to address the massive wearable biosensing opportunity emerging at the intersection between existing wearable devices and lab tests to better mitigate patients risks, anytime anywhere. The Mayo Clinic in the US is a shareholder of Xsensio, and we're currently establishing a strategic collaboration with a large US chip manufacturer.

With the Series A we are currently closing with a large VC firm from the US & Taiwan, we aim to accelerate clinical validation and industrialisation.